Article citationsMore>>

Manfredi, E., Lumetti, S., Rivara, F., Toffoli, A., Calciolari, E., Cacchioli, A., Ravanetti, F., Ghiacci, G., Macaluso, G. and Galli, C.L. (2016) Role of Prostaglandin E2 in the Modulation of Wnt Canonical Signaling in Cells on Microstructured Titanium Surfaces. Journal of Applied Biomaterials and Functional Materials, 14, e181-e188.
https://doi.org/10.5301/jabfm.5000267

has been cited by the following article:

• TITLE: The Role of Prostaglandin E2 on Osteoblast Proliferation Induced by Hydroxyapatite

  AUTHORS: Erwan Sugiatno, Endang Herminajeng, Wihaskoro Sosroseno

  KEYWORDS: Hydroxyapatite, Osteoblast, PGE2, Proliferation

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.8 No.1, January 8, 2020

  ABSTRACT: Objective: Prostaglandin E2 (PGE2) plays a crucial role in regulating bone cell differentiation and proliferation. The aim of the present study was to determine whether PGE2 may regulate osteoblast proliferation induced by hydroxyapatite. Materials and Methods: Osteoblasts (HOS cell line) pre-treated with cyclooxygenase (COX) inhibitors (indomethacin, aspirin and nimesulide) were then cultured. The cells were also pre-treated with or without nimesulide and then cultured with PGE2. The cell cultures were also treated with SQ22536 (adenylyl cyclase inhibitor) and added with Db-cAMP (cAMP analog), and/or PGE2. KT5720 [protein kinase A (PKA) inhibitor.], Db-cAMP and/or forskolin (adenylyl cyclase activator)-treated cultures were used to assess the role of PKA. The role of EP2 and/or EP4 was determined by using EP2 antagonist (PF-04418948) and EP4 antagonist (L-161,982) with PGE2. All cells were cultured with or without hydroxyapatite. The levels of PGE2 and cAMP were detected from the culture supernantants and the cell proliferation was assessed colorimetrically. Results: Nimesulide and indomethacin but not aspirin suppressed partially the cell proliferation but fully PGE2 production. PGE2 abrogated nimesulide-mediated suppression of cell proliferation. The cell proliferation was enhanced by low but suppressed by high concentration of PGE2. Moreover, the SQ22536-mediated suppression of cell proliferation was abolished by Db-cAMP but not PGE2. Conversely, PGE2, Db-cAMP or forskolin failed to eliminate KT5720-mediated suppression of cell proliferation. The effect of PGE2 on cell proliferation and cAMP levels was mediated predominantly via EP2 and to a lesser extent, EP4. The results of the controls for all experiments were significantly lower than hydroxyapatite-stimulated cell cultures. Conclusion: These results suggest thatPGE2, acting via a COX-2-, cAMP-PKA- and both EP2 and EP4-dependent pathway may partially regulate hydroxyapatite-induced human osteoblasts in an autocrine fashion.